| 摘要 |
Use of 1-(4-(5-cyanoindol-3-yl)butyl)-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or its physiologically acceptable salts for the manufacture of medicaments for the treatment of sub-type anxiety disorders, is new. Use of 1-(4-(5-cyanoindol-3-yl)butyl)-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or its physiologically acceptable salts for the manufacture of medicaments for the treatment of sub-type anxiety disorders chosen from the sub-types panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, post-traumatic stress disorder, acute stress indication and/or generalized anxiety disorder. ACTIVITY : Tranquilizer; nootropic; antimanic; antiaddictive; anorectic. No biological data is given. MECHANISM OF ACTION : Selective serotonin reuptake inhibitor; 5-HT 1A-receptor agonist. |
